| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |